Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CB1-IN-2
Cat. No.:
OB0425LY-161
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
CB1-IN-2 is a selective CB1 inhibitor that blocks the action of cannabinoid receptors.
Synonyms:
2527805-39-4; CB1-IN-2; CB1IN2
CAS No.:
2527805-39-4
Formula:
C17H19Cl2N5O
Formula Weight:
380.27
Specification
Target:
Cannabinoid receptor
Pathway:
GPCR/G protein; Neuronal signaling; MAPK/ERK pathway; Stem cell/Wnt
Storage:
Storage at -20°C.
Applications:
CB1-IN-2 is primarily used in the study of obesity and related metabolic disorders, but also has potential applications in anxiety and depression.
